nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—HTR2A—Alzheimer's disease	0.157	0.522	CbGaD
Cisapride—HTR3A—Memantine—Alzheimer's disease	0.156	0.275	CbGbCtD
Cisapride—CYP2D6—Alzheimer's disease	0.144	0.478	CbGaD
Cisapride—HTR2A—Donepezil—Alzheimer's disease	0.0732	0.129	CbGbCtD
Cisapride—CYP2A6—Memantine—Alzheimer's disease	0.0671	0.118	CbGbCtD
Cisapride—DRD2—Memantine—Alzheimer's disease	0.0584	0.103	CbGbCtD
Cisapride—CYP2B6—Memantine—Alzheimer's disease	0.0437	0.0769	CbGbCtD
Cisapride—CYP2D6—Rivastigmine—Alzheimer's disease	0.0304	0.0536	CbGbCtD
Cisapride—CYP2C19—Memantine—Alzheimer's disease	0.0278	0.0488	CbGbCtD
Cisapride—CYP2C9—Donepezil—Alzheimer's disease	0.0266	0.0468	CbGbCtD
Cisapride—CYP2D6—Donepezil—Alzheimer's disease	0.0243	0.0428	CbGbCtD
Cisapride—CYP3A4—Rivastigmine—Alzheimer's disease	0.0194	0.0341	CbGbCtD
Cisapride—CYP2D6—Galantamine—Alzheimer's disease	0.0157	0.0276	CbGbCtD
Cisapride—CYP3A4—Donepezil—Alzheimer's disease	0.0155	0.0272	CbGbCtD
Cisapride—HTR2C—choroid plexus—Alzheimer's disease	0.0104	0.196	CbGeAlD
Cisapride—CYP3A4—Galantamine—Alzheimer's disease	0.00997	0.0175	CbGbCtD
Cisapride—HTR2A—choroid plexus—Alzheimer's disease	0.00521	0.0985	CbGeAlD
Cisapride—HTR4—telencephalon—Alzheimer's disease	0.00336	0.0636	CbGeAlD
Cisapride—HTR2A—locus ceruleus—Alzheimer's disease	0.00322	0.0608	CbGeAlD
Cisapride—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00304	0.0575	CbGeAlD
Cisapride—HTR2A—cerebellar cortex—Alzheimer's disease	0.00262	0.0496	CbGeAlD
Cisapride—DRD2—telencephalic ventricle—Alzheimer's disease	0.00231	0.0437	CbGeAlD
Cisapride—HTR2A—telencephalic ventricle—Alzheimer's disease	0.00153	0.0288	CbGeAlD
Cisapride—HTR4—brain—Alzheimer's disease	0.00152	0.0287	CbGeAlD
Cisapride—Iloperidone—HTR6—Alzheimer's disease	0.00131	0.494	CrCbGaD
Cisapride—HTR3A—forebrain—Alzheimer's disease	0.000988	0.0187	CbGeAlD
Cisapride—HTR3A—telencephalon—Alzheimer's disease	0.000908	0.0172	CbGeAlD
Cisapride—HTR2C—forebrain—Alzheimer's disease	0.000795	0.015	CbGeAlD
Cisapride—HTR2A—blood vessel—Alzheimer's disease	0.000755	0.0143	CbGeAlD
Cisapride—HTR2B—forebrain—Alzheimer's disease	0.000746	0.0141	CbGeAlD
Cisapride—HTR2C—telencephalon—Alzheimer's disease	0.000731	0.0138	CbGeAlD
Cisapride—HTR2B—telencephalon—Alzheimer's disease	0.000686	0.013	CbGeAlD
Cisapride—DRD2—forebrain—Alzheimer's disease	0.000604	0.0114	CbGeAlD
Cisapride—KCNH2—forebrain—Alzheimer's disease	0.000595	0.0113	CbGeAlD
Cisapride—DRD2—telencephalon—Alzheimer's disease	0.000556	0.0105	CbGeAlD
Cisapride—KCNH2—telencephalon—Alzheimer's disease	0.000547	0.0103	CbGeAlD
Cisapride—HTR3A—nervous system—Alzheimer's disease	0.000536	0.0101	CbGeAlD
Cisapride—HTR3A—central nervous system—Alzheimer's disease	0.000516	0.00976	CbGeAlD
Cisapride—CYP2A6—cerebellum—Alzheimer's disease	0.000496	0.00937	CbGeAlD
Cisapride—HTR2A—embryo—Alzheimer's disease	0.000451	0.00852	CbGeAlD
Cisapride—HTR2C—nervous system—Alzheimer's disease	0.000431	0.00815	CbGeAlD
Cisapride—HTR2C—central nervous system—Alzheimer's disease	0.000415	0.00785	CbGeAlD
Cisapride—HTR3A—brain—Alzheimer's disease	0.00041	0.00775	CbGeAlD
Cisapride—HTR2B—nervous system—Alzheimer's disease	0.000405	0.00766	CbGeAlD
Cisapride—CYP2A6—brain—Alzheimer's disease	0.000403	0.00761	CbGeAlD
Cisapride—HTR2A—forebrain—Alzheimer's disease	0.000399	0.00753	CbGeAlD
Cisapride—HTR2B—central nervous system—Alzheimer's disease	0.00039	0.00737	CbGeAlD
Cisapride—Iloperidone—HTR2A—Alzheimer's disease	0.000385	0.145	CrCbGaD
Cisapride—HTR2A—telencephalon—Alzheimer's disease	0.000366	0.00693	CbGeAlD
Cisapride—CYP2D6—forebrain—Alzheimer's disease	0.000363	0.00686	CbGeAlD
Cisapride—Iloperidone—CYP2D6—Alzheimer's disease	0.000352	0.133	CrCbGaD
Cisapride—Metoclopramide—CYP2D6—Alzheimer's disease	0.000349	0.132	CrCbGaD
Cisapride—CYP2D6—telencephalon—Alzheimer's disease	0.000334	0.00631	CbGeAlD
Cisapride—HTR2C—brain—Alzheimer's disease	0.00033	0.00623	CbGeAlD
Cisapride—DRD2—nervous system—Alzheimer's disease	0.000328	0.0062	CbGeAlD
Cisapride—KCNH2—nervous system—Alzheimer's disease	0.000323	0.00611	CbGeAlD
Cisapride—DRD2—central nervous system—Alzheimer's disease	0.000316	0.00597	CbGeAlD
Cisapride—KCNH2—central nervous system—Alzheimer's disease	0.000311	0.00588	CbGeAlD
Cisapride—HTR2B—brain—Alzheimer's disease	0.00031	0.00585	CbGeAlD
Cisapride—DRD2—cerebellum—Alzheimer's disease	0.000309	0.00583	CbGeAlD
Cisapride—KCNH2—cerebellum—Alzheimer's disease	0.000304	0.00575	CbGeAlD
Cisapride—CYP2B6—nervous system—Alzheimer's disease	0.000265	0.00501	CbGeAlD
Cisapride—CYP2B6—central nervous system—Alzheimer's disease	0.000255	0.00483	CbGeAlD
Cisapride—Gefitinib—CYP2D6—Alzheimer's disease	0.000254	0.0957	CrCbGaD
Cisapride—DRD2—brain—Alzheimer's disease	0.000251	0.00474	CbGeAlD
Cisapride—KCNH2—brain—Alzheimer's disease	0.000247	0.00467	CbGeAlD
Cisapride—CYP2C8—brain—Alzheimer's disease	0.000226	0.00427	CbGeAlD
Cisapride—HTR2A—nervous system—Alzheimer's disease	0.000216	0.00409	CbGeAlD
Cisapride—HTR2A—central nervous system—Alzheimer's disease	0.000208	0.00394	CbGeAlD
Cisapride—HTR2A—cerebellum—Alzheimer's disease	0.000204	0.00385	CbGeAlD
Cisapride—CYP2B6—brain—Alzheimer's disease	0.000203	0.00383	CbGeAlD
Cisapride—CYP3A4—nervous system—Alzheimer's disease	0.0002	0.00379	CbGeAlD
Cisapride—CYP2D6—nervous system—Alzheimer's disease	0.000197	0.00372	CbGeAlD
Cisapride—CYP3A4—central nervous system—Alzheimer's disease	0.000193	0.00364	CbGeAlD
Cisapride—CYP2D6—central nervous system—Alzheimer's disease	0.00019	0.00359	CbGeAlD
Cisapride—CYP2D6—cerebellum—Alzheimer's disease	0.000185	0.00351	CbGeAlD
Cisapride—HTR2A—brain—Alzheimer's disease	0.000165	0.00313	CbGeAlD
Cisapride—CYP2D6—brain—Alzheimer's disease	0.000151	0.00285	CbGeAlD
Cisapride—DRD2—Signaling Pathways—IGF2—Alzheimer's disease	5.46e-06	7.31e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	5.45e-06	7.31e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—NGF—Alzheimer's disease	5.43e-06	7.28e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	5.43e-06	7.27e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IGF2—Alzheimer's disease	5.37e-06	7.2e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—BCHE—Alzheimer's disease	5.35e-06	7.17e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—CALM1—Alzheimer's disease	5.29e-06	7.09e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—ENO1—Alzheimer's disease	5.29e-06	7.09e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	5.29e-06	7.09e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CCR5—Alzheimer's disease	5.28e-06	7.08e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IGF1R—Alzheimer's disease	5.28e-06	7.07e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—APOE—Alzheimer's disease	5.27e-06	7.07e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	5.24e-06	7.03e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—ENO1—Alzheimer's disease	5.24e-06	7.03e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—CAV1—Alzheimer's disease	5.23e-06	7e-05	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—AKT1—Alzheimer's disease	5.23e-06	7e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IGF1R—Alzheimer's disease	5.19e-06	6.96e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—HTR2A—Alzheimer's disease	5.17e-06	6.93e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—GSK3B—Alzheimer's disease	5.16e-06	6.91e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	5.14e-06	6.89e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CREB1—Alzheimer's disease	5.12e-06	6.86e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—INS—Alzheimer's disease	5.09e-06	6.82e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—LPL—Alzheimer's disease	5.08e-06	6.81e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—LPL—Alzheimer's disease	5.06e-06	6.78e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	5.04e-06	6.76e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MEF2C—Alzheimer's disease	5.01e-06	6.72e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PPARG—Alzheimer's disease	5.01e-06	6.72e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CCL2—Alzheimer's disease	5.01e-06	6.71e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—LPL—Alzheimer's disease	4.98e-06	6.67e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—LPL—Alzheimer's disease	4.96e-06	6.65e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.95e-06	6.63e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MEF2C—Alzheimer's disease	4.93e-06	6.61e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IGF1—Alzheimer's disease	4.92e-06	6.6e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PRKCG—Alzheimer's disease	4.92e-06	6.59e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—BCHE—Alzheimer's disease	4.92e-06	6.59e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—INS—Alzheimer's disease	4.92e-06	6.59e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	4.9e-06	6.57e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	4.89e-06	6.55e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—BCHE—Alzheimer's disease	4.87e-06	6.53e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PRKCG—Alzheimer's disease	4.84e-06	6.49e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CALM1—Alzheimer's disease	4.82e-06	6.46e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—APOE—Alzheimer's disease	4.8e-06	6.44e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—LEP—Alzheimer's disease	4.8e-06	6.44e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—NGF—Alzheimer's disease	4.79e-06	6.42e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ACHE—Alzheimer's disease	4.78e-06	6.41e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CAV1—Alzheimer's disease	4.76e-06	6.38e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CHAT—Alzheimer's disease	4.76e-06	6.38e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—TPI1—Alzheimer's disease	4.76e-06	6.38e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	4.73e-06	6.34e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	4.72e-06	6.33e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NGF—Alzheimer's disease	4.71e-06	6.32e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	4.7e-06	6.3e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CCR5—Alzheimer's disease	4.66e-06	6.25e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	4.64e-06	6.22e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	4.6e-06	6.16e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PPARG—Alzheimer's disease	4.59e-06	6.16e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—ESR1—Alzheimer's disease	4.59e-06	6.15e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CCR5—Alzheimer's disease	4.59e-06	6.15e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—MTHFR—Alzheimer's disease	4.57e-06	6.13e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—MAOB—Alzheimer's disease	4.56e-06	6.12e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HTR2A—Alzheimer's disease	4.56e-06	6.11e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—F2—Alzheimer's disease	4.53e-06	6.07e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.51e-06	6.05e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—INS—Alzheimer's disease	4.51e-06	6.04e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	4.5e-06	6.03e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	4.48e-06	6.01e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ENO1—Alzheimer's disease	4.48e-06	6.01e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	4.47e-06	5.99e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—NOS3—Alzheimer's disease	4.46e-06	5.98e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	4.46e-06	5.98e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—NOTCH1—Alzheimer's disease	4.43e-06	5.94e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	4.39e-06	5.89e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	4.39e-06	5.89e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—NOS3—Alzheimer's disease	4.31e-06	5.78e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—LPL—Alzheimer's disease	4.3e-06	5.76e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CALM1—Alzheimer's disease	4.27e-06	5.72e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—APOE—Alzheimer's disease	4.26e-06	5.7e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CALM1—Alzheimer's disease	4.26e-06	5.7e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—A2M—Alzheimer's disease	4.24e-06	5.69e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—LEP—Alzheimer's disease	4.24e-06	5.68e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—APOE—Alzheimer's disease	4.24e-06	5.68e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CAV1—Alzheimer's disease	4.22e-06	5.65e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	4.21e-06	5.65e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CAV1—Alzheimer's disease	4.2e-06	5.63e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	4.2e-06	5.62e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CALM1—Alzheimer's disease	4.19e-06	5.61e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CALM1—Alzheimer's disease	4.17e-06	5.6e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—APOE—Alzheimer's disease	4.17e-06	5.59e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—LEP—Alzheimer's disease	4.17e-06	5.59e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—BCHE—Alzheimer's disease	4.17e-06	5.58e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—GSK3B—Alzheimer's disease	4.16e-06	5.58e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—APOE—Alzheimer's disease	4.16e-06	5.58e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CAV1—Alzheimer's disease	4.13e-06	5.54e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CREB1—Alzheimer's disease	4.13e-06	5.53e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CAV1—Alzheimer's disease	4.12e-06	5.52e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—INS—Alzheimer's disease	4.1e-06	5.5e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	4.05e-06	5.43e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CCL2—Alzheimer's disease	4.04e-06	5.41e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—F2—Alzheimer's disease	4e-06	5.36e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	3.98e-06	5.34e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	3.97e-06	5.32e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—NOS3—Alzheimer's disease	3.95e-06	5.3e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	3.94e-06	5.29e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—F2—Alzheimer's disease	3.93e-06	5.27e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	3.93e-06	5.27e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	3.91e-06	5.24e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	3.88e-06	5.2e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	3.87e-06	5.19e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	3.86e-06	5.17e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.86e-06	5.17e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.85e-06	5.16e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	3.84e-06	5.15e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—LPL—Alzheimer's disease	3.84e-06	5.14e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	3.83e-06	5.13e-05	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—AKT1—Alzheimer's disease	3.82e-06	5.12e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	3.81e-06	5.11e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CASP3—Alzheimer's disease	3.79e-06	5.08e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—IL6—Alzheimer's disease	3.76e-06	5.04e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PPARG—Alzheimer's disease	3.71e-06	4.97e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ACHE—Alzheimer's disease	3.69e-06	4.95e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	3.67e-06	4.92e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	3.65e-06	4.89e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	3.64e-06	4.88e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—INS—Alzheimer's disease	3.64e-06	4.87e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PPARG—Alzheimer's disease	3.62e-06	4.86e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—INS—Alzheimer's disease	3.62e-06	4.86e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CALM1—Alzheimer's disease	3.62e-06	4.85e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PTGS2—Alzheimer's disease	3.61e-06	4.84e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	3.61e-06	4.84e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—APOE—Alzheimer's disease	3.6e-06	4.83e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	3.6e-06	4.82e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	3.58e-06	4.8e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CAV1—Alzheimer's disease	3.57e-06	4.78e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—INS—Alzheimer's disease	3.56e-06	4.78e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	3.56e-06	4.78e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—INS—Alzheimer's disease	3.55e-06	4.76e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—LPL—Alzheimer's disease	3.53e-06	4.73e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	3.51e-06	4.7e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	3.5e-06	4.7e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—LPL—Alzheimer's disease	3.5e-06	4.69e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MAPK8—Alzheimer's disease	3.48e-06	4.67e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—AKT1—Alzheimer's disease	3.47e-06	4.65e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ENO1—Alzheimer's disease	3.46e-06	4.63e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	3.46e-06	4.63e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	3.45e-06	4.63e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	3.45e-06	4.62e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	3.39e-06	4.55e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	3.28e-06	4.4e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	3.27e-06	4.38e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CALM1—Alzheimer's disease	3.23e-06	4.33e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—APOE—Alzheimer's disease	3.22e-06	4.31e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—BCHE—Alzheimer's disease	3.21e-06	4.31e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—VEGFA—Alzheimer's disease	3.21e-06	4.31e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—NOS3—Alzheimer's disease	3.19e-06	4.27e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CAV1—Alzheimer's disease	3.19e-06	4.27e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	3.18e-06	4.26e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	3.18e-06	4.26e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	3.15e-06	4.22e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PPARG—Alzheimer's disease	3.14e-06	4.21e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	3.13e-06	4.19e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—NOS3—Alzheimer's disease	3.12e-06	4.18e-05	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	3.08e-06	4.13e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—INS—Alzheimer's disease	3.08e-06	4.13e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	3.06e-06	4.1e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	3.04e-06	4.07e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	3.03e-06	4.07e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—LPL—Alzheimer's disease	2.99e-06	4.01e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CALM1—Alzheimer's disease	2.97e-06	3.98e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—APOE—Alzheimer's disease	2.96e-06	3.96e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	2.95e-06	3.95e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CALM1—Alzheimer's disease	2.94e-06	3.94e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	2.94e-06	3.94e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—APOE—Alzheimer's disease	2.93e-06	3.93e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CAV1—Alzheimer's disease	2.93e-06	3.93e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	2.92e-06	3.91e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CAV1—Alzheimer's disease	2.91e-06	3.89e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	2.85e-06	3.82e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	2.81e-06	3.76e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PPARG—Alzheimer's disease	2.8e-06	3.75e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	2.8e-06	3.75e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—INS—Alzheimer's disease	2.75e-06	3.68e-05	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	2.72e-06	3.65e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—NOS3—Alzheimer's disease	2.7e-06	3.62e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	2.7e-06	3.61e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	2.69e-06	3.61e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	2.68e-06	3.59e-05	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.68e-06	3.59e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	2.65e-06	3.56e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	2.64e-06	3.53e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	2.59e-06	3.48e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.58e-06	3.45e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PPARG—Alzheimer's disease	2.55e-06	3.42e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.53e-06	3.4e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—INS—Alzheimer's disease	2.53e-06	3.39e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.52e-06	3.38e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CALM1—Alzheimer's disease	2.51e-06	3.37e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—APOE—Alzheimer's disease	2.51e-06	3.36e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—INS—Alzheimer's disease	2.51e-06	3.36e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CAV1—Alzheimer's disease	2.48e-06	3.33e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	2.48e-06	3.32e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	2.47e-06	3.31e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	2.47e-06	3.31e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	2.44e-06	3.27e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	2.43e-06	3.26e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	2.43e-06	3.26e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—NOS3—Alzheimer's disease	2.41e-06	3.23e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	2.38e-06	3.19e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.31e-06	3.09e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	2.29e-06	3.07e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	2.25e-06	3.02e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	2.22e-06	2.98e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.22e-06	2.97e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	2.2e-06	2.95e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—NOS3—Alzheimer's disease	2.2e-06	2.94e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PPARG—Alzheimer's disease	2.18e-06	2.93e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—INS—Alzheimer's disease	2.14e-06	2.87e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	2.1e-06	2.82e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.08e-06	2.78e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	2.07e-06	2.77e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	2.05e-06	2.75e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.03e-06	2.72e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	2.01e-06	2.69e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—AKT1—Alzheimer's disease	1.98e-06	2.66e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.96e-06	2.63e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.94e-06	2.6e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.93e-06	2.59e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.92e-06	2.57e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.88e-06	2.52e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—AKT1—Alzheimer's disease	1.82e-06	2.43e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.79e-06	2.4e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TP53—Alzheimer's disease	1.73e-06	2.32e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.72e-06	2.3e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	1.7e-06	2.28e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.68e-06	2.26e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.65e-06	2.22e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—INS—Alzheimer's disease	1.65e-06	2.21e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IL6—Alzheimer's disease	1.58e-06	2.12e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	1.56e-06	2.09e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—AKT1—Alzheimer's disease	1.47e-06	1.96e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	1.46e-06	1.96e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.45e-06	1.94e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	1.44e-06	1.93e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—AKT1—Alzheimer's disease	1.43e-06	1.92e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.33e-06	1.78e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—AKT1—Alzheimer's disease	1.24e-06	1.66e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.11e-06	1.48e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.02e-06	1.37e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.01e-06	1.35e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—AKT1—Alzheimer's disease	8.63e-07	1.16e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—AKT1—Alzheimer's disease	6.66e-07	8.93e-06	CbGpPWpGaD
